Smartwatches could read Parkinson's quality of life

NCT ID NCT06209502

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This observational study explores whether data from everyday smartwatches and smartphones can be used to remotely assess the health-related quality of life of people with Parkinson's disease. Researchers will develop an algorithm, called the Q-index, based on passively collected data from these devices. The study includes 95 participants with Parkinson's disease at various stages, aiming to see if this approach can monitor quality of life without frequent clinic visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Wearable and portable devices (smartwatch and smartphone) with the Koios Care app
What this could lead to
If successful, this could enable remote, passive monitoring of quality of life in Parkinson's patients, potentially improving care and reducing clinic visits.
What could go wrong
This is an early proof-of-concept study with a small number of participants. The algorithm may not be accurate enough for clinical use, and results may not generalize to all Parkinson's patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AZ Delta, Department of Neurology, EC reference 23045

    Roeselare, 8800, Belgium

  • AZ Oostende, Department of Neurology, EC reference OG-057

    Ostend, Belgium

  • CHU Charleroi, Department of Neurology, EC reference AH/SG-2023-037

    Charleroi, Belgium

  • CHU de Liege, Department of Neurology, EC reference 2023/173

    Liège, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.